1. Home
  2. LOAN vs ADVM Comparison

LOAN vs ADVM Comparison

Compare LOAN & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • ADVM
  • Stock Information
  • Founded
  • LOAN 1989
  • ADVM 2006
  • Country
  • LOAN United States
  • ADVM United States
  • Employees
  • LOAN N/A
  • ADVM N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LOAN Real Estate
  • ADVM Health Care
  • Exchange
  • LOAN Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • LOAN 58.1M
  • ADVM 47.4M
  • IPO Year
  • LOAN 1999
  • ADVM 2014
  • Fundamental
  • Price
  • LOAN $5.20
  • ADVM $2.25
  • Analyst Decision
  • LOAN
  • ADVM Strong Buy
  • Analyst Count
  • LOAN 0
  • ADVM 5
  • Target Price
  • LOAN N/A
  • ADVM $26.40
  • AVG Volume (30 Days)
  • LOAN 13.6K
  • ADVM 186.4K
  • Earning Date
  • LOAN 07-21-2025
  • ADVM 08-11-2025
  • Dividend Yield
  • LOAN 8.79%
  • ADVM N/A
  • EPS Growth
  • LOAN N/A
  • ADVM N/A
  • EPS
  • LOAN 0.48
  • ADVM N/A
  • Revenue
  • LOAN $7,291,468.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • LOAN N/A
  • ADVM N/A
  • Revenue Next Year
  • LOAN $4.41
  • ADVM $18.82
  • P/E Ratio
  • LOAN $10.90
  • ADVM N/A
  • Revenue Growth
  • LOAN N/A
  • ADVM N/A
  • 52 Week Low
  • LOAN $4.74
  • ADVM $1.78
  • 52 Week High
  • LOAN $6.05
  • ADVM $10.14
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 50.76
  • ADVM 40.11
  • Support Level
  • LOAN $5.13
  • ADVM $2.21
  • Resistance Level
  • LOAN $5.20
  • ADVM $3.10
  • Average True Range (ATR)
  • LOAN 0.10
  • ADVM 0.22
  • MACD
  • LOAN 0.01
  • ADVM -0.00
  • Stochastic Oscillator
  • LOAN 47.93
  • ADVM 4.49

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: